Listed by the USPTO as MERRIAM, AARON ROGERS
Tech Center 3700 • Art Units: 3791
This examiner grants 33% of resolved cases
MERRIAM, AARON ROGERS is assigned to tech center 3700 and art unit 3791. The profile covers 39 resolved cases and shows a 33.3% allowance rate. The interview lift is 65.0%, a strong positive association in this record. The median time to allowance is 1385 days, indicating a lengthy prosecution timeline for matters that reach allowance.
The listed companies are Medtronic Minimed Inc., Panasonic Holdings Corporation, and Honor Device Co., Ltd. The listed firms are BIRCH STEWART KOLASCH & BIRCH, LLP, CRGO Global, and DENTONS BINGHAM GREENEBAUM LLP. Because the resolved-case record is limited, the figures should be treated as an early profile rather than a settled long-term pattern. The relationship between the lower allowance rate and high interview lift supports preparing carefully for interviews while recognizing that the available sample is small.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17939217 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM | Non-Final OA | CANON MEDICAL SYSTEMS CORPORATION |
| 19054808 | INFORMATION PROCESSING METHOD AND INFORMATION PROCESSING SYSTEM | Non-Final OA | Panasonic Holdings Corporation |
| 18580433 | WEARABLE ELECTRONIC APPARATUS, BODY TEMPERATURE MEASUREMENT METHOD, AND WEARABLE ELECTRONIC DEVICE | Non-Final OA | Honor Device Co., Ltd. |
| 18584978 | DETERMINING A PHYSIOLOGICAL PARAMETER USING OPTICAL SIGNALS | Final Rejection | QUALCOMM Incorporated |
| 18194286 | SYSTEM FEATURING OPTICAL AND ELECTRICAL SENSORS FOR CHARACTERIZING EFFLUENT FROM A PERITONEAL DIALYSIS PATIENT | Non-Final OA | BAXTER HEALTHCARE SA |
| 17766352 | INTRAVENOUS INFILTRATION SENSOR DEVICE | Final Rejection | Murata Manufacturing Co., Ltd. |
| 19306885 | BLOOD-VESSEL-ANCHORED CARDIAC SENSOR | Final Rejection | EDWARDS LIFESCIENCES CORPORATION |
| 17481757 | AUTOMATIC DISABLING OF ALERTS FOR DIABETIC CONDITIONS | Non-Final OA | Medtronic MiniMed, Inc. |
| 19075679 | Automated Weight Based Fluid Output Monitoring System | Non-Final OA | C. R. Bard, Inc. |
| 18486138 | SECURE BROADCAST MESSAGING IN SUPPORT OF GLUCOSE MONITORING | Final Rejection | Dexcom, Inc. |
| 19097105 | Hemodynamic Sensor Systems for Predicting and Diagnosing Hypotension and Characterizing Interventions Thereof | Non-Final OA | Becton, Dickinson and Company |
| 17656660 | TERRITORY MAPPING IN PSEUDO-CONTINUOUS ARTERIAL SPIN LABELING | Non-Final OA | The Trustees of The University of Pennsylvania |
| 17639825 | SYSTEMS AND METHODS FOR DETECTION AND GRADING OF DIABETIC RETINOPATHY | Final Rejection | University of Louisville Research Foundation, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy33.3% of resolved applications examined by Aaron Rogers Merriam were allowed (39 resolved cases), compared with 53.3% across Art Unit 3791 over the last five years.
This examiner's interview lift is +65.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Aaron Rogers Merriam took 1,385 days on average from filing to allowance.
Aaron Rogers Merriam examines applications in Art Unit 3791 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
